世界の体外式CO2除去装置市場2022-2028:製品別(体外式CO2除去装置、使い捨て型用品、その他)、用途別、エンドユーザー別、地域別

【英語タイトル】Global Extracorporeal CO2 Removal Devices market Size study, by Product (Extracorporeal CO2 Devices, Disposables, and Others), Application (Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS), Bridge to Lung Transplant, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others) and Regional Forecasts 2022-2028

Bizwit Research & Consultingが出版した調査資料(BZW22OT0072)・商品コード:BZW22OT0072
・発行会社(調査会社):Bizwit Research & Consulting
・発行日:2022年9月6日
・ページ数:約200
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥633,600見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥800,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Bizwit社の本市場調査資料では、2021年におよそXXX百万ドルであった世界の体外式CO2除去装置市場規模が、2022年から2028年の間にXX%以上成長すると予測しています。本書では、体外式CO2除去装置の世界市場について調査し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析(新型コロナウイルス感染症の影響)、製品別(体外式CO2装置、使い捨て型、その他)分析、用途別(慢性閉塞性肺疾患(COPD)、急性呼吸窮迫症候群(ARDS)、肺移植、その他)分析、エンドユーザー別(病院・クリニック、外来手術センター、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、その他)分析、競争状況、調査プロセスなどを整理しております。本書では、Medtronic、Getinge AB、Xenios AG、Alung Technologies、ESTOR S.P.A、Medica Spa、Aferectica Srlなどの企業情報が含まれています。

・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析(新型コロナウイルス感染症の影響)

・世界の体外式CO2除去装置市場規模:製品別
- 体外式CO2装置の市場規模
- 使い捨て型体外式CO2除去装置の市場規模
- その他製品の市場規模

・世界の体外式CO2除去装置市場規模:用途別
- 慢性閉塞性肺疾患(COPD)用体外式CO2除去装置の市場規模
- 急性呼吸窮迫症候群(ARDS)用体外式CO2除去装置の市場規模
- 肺移植用体外式CO2除去装置の市場規模
- その他用途における市場規模

・世界の体外式CO2除去装置市場規模:エンドユーザー別
- 病院・クリニックにおける市場規模
- 外来手術センターにおける市場規模
- その他エンドユーザーにおける市場規模

・世界の体外式CO2除去装置市場規模:地域別
- 北米の体外式CO2除去装置市場規模
- ヨーロッパの体外式CO2除去装置市場規模
- アジア太平洋の体外式CO2除去装置市場規模
- 中南米の体外式CO2除去装置市場規模
- その他地域の体外式CO2除去装置市場規模

・競争状況
・調査プロセス
❖ レポートの概要 ❖

Global Extracorporeal CO2 Removal Devices market is valued at approximately USD XXX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Artificial gas exchange takes a different route with extracorporeal carbon dioxide removal (ECCO2R). When a person has increased blood levels of carbon dioxide as a result of respiratory failure, extracorporeal carbon dioxide removal is used to reduce those levels.
The market growth is driven by increasing prevalence of COPD and other diseases and increasing numbers of product launches and approvals. For instance, according to a research study released in February 2021 and titled “Burden of COPD among population above 30 years in India: methodology for a systematic review and suggested meta-analysis,” the estimated overall prevalence of COPD in low- and middle-income countries was 9.2%, and meta-analysis indicated that the prevalence of COPD among persons aged 30 years and over was 10.6% in low- and middle-income countries. Alung Technologies also received De Novo Clearance for the hemolung respiratory system in November 2021. The FDA has authorized this system as the first ECCO2R product. X-COR Therapeutics completed a fundraising round of around 2.6 million in November 2020. This business plans to use these funds to continue developing its products, which include ECCO2R devices. Moreover, increasing cases of respiratory emergencies and chronic obstructive pulmonary disease and rising preference for safe and rapid minimally invasive ventilation devices propel the market opportunities in the upcoming years. However, risks of complications during extracorporeal co2 removal therapy impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Extracorporeal CO2 Removal Devices Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is leading the overall market revenue share owing to improved healthcare infrastructure and high adoption of extracorporeal CO2 removal devices. However, Asia Pacific is expected to be the fastest growing region due to rising awareness regarding acute respiratory failure and increasing government healthcare expenditure in developing countries.

Major market players included in this report are:
Medtronic
Getinge AB
Xenios AG
Alung Technologies
ESTOR S.P.A
Medica Spa
Aferectica Srl

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Application offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Extracorporeal CO2 Devices
Disposables
Others

By Application:
Chronic Obstructive Pulmonary Disease (COPD)
Acute Respiratory Distress Syndrome (ARDS)
Bridge to Lung Transplant
Others

By End User:
Hospitals and Clinics
Ambulatory Surgical Centers
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Extracorporeal CO2 Removal Devices market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

❖ レポートの目次 ❖

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. Extracorporeal CO2 Removal Devices Market, by region, 2020-2028 (USD Million)
1.2.2. Extracorporeal CO2 Removal Devices Market, by Product, 2020-2028 (USD Million)
1.2.3. Extracorporeal CO2 Removal Devices Market, by Application, 2020-2028 (USD Million)
1.2.4. Extracorporeal CO2 Removal Devices Market, by End User, 2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Extracorporeal CO2 Removal Devices Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Extracorporeal CO2 Removal Devices Market Dynamics
3.1. Extracorporeal CO2 Removal Devices Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of COPD and other diseases
3.1.1.2. Increasing numbers of product launches and approvals
3.1.2. Market Challenges
3.1.2.1. Risks of complications during extracorporeal co2 removal therapy
3.1.3. Market Opportunities
3.1.3.1. Increasing cases of respiratory emergencies and chronic obstructive pulmonary disease
3.1.3.2. Rising preference for safe and rapid minimally invasive ventilation devices
Chapter 4. Global Extracorporeal CO2 Removal Devices Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Extracorporeal CO2 Removal Devices Market, by Product
6.1. Market Snapshot
6.2. Global Extracorporeal CO2 Removal Devices Market by Product, Performance – Potential Analysis
6.3. Global Extracorporeal CO2 Removal Devices Market Estimates & Forecasts by Product, 2018-2028 (USD Million)
6.4. Extracorporeal CO2 Removal Devices Market, Sub Segment Analysis
6.4.1. Extracorporeal CO2 Devices
6.4.2. Disposables
6.4.3. Others
Chapter 7. Global Extracorporeal CO2 Removal Devices Market, by Application
7.1. Market Snapshot
7.2. Global Extracorporeal CO2 Removal Devices Market by Application, Performance – Potential Analysis
7.3. Global Extracorporeal CO2 Removal Devices Market Estimates & Forecasts by Application, 2018-2028 (USD Million)
7.4. Extracorporeal CO2 Removal Devices Market, Sub Segment Analysis
7.4.1. Chronic Obstructive Pulmonary Disease (COPD)
7.4.2. Acute Respiratory Distress Syndrome (ARDS)
7.4.3. Bridge to Lung Transplant
7.4.4. Others
Chapter 8. Global Extracorporeal CO2 Removal Devices Market, by End User
8.1. Market Snapshot
8.2. Global Extracorporeal CO2 Removal Devices Market by End User, Performance – Potential Analysis
8.3. Global Extracorporeal CO2 Removal Devices Market Estimates & Forecasts by End User, 2018-2028 (USD Million)
8.4. Extracorporeal CO2 Removal Devices Market, Sub Segment Analysis
8.4.1. Hospitals and Clinics
8.4.2. Ambulatory Surgical Centers
8.4.3. Others
Chapter 9. Global Extracorporeal CO2 Removal Devices Market, Regional Analysis
9.1. Extracorporeal CO2 Removal Devices Market, Regional Market Snapshot
9.2. North America Extracorporeal CO2 Removal Devices Market
9.2.1. U.S. Extracorporeal CO2 Removal Devices Market
9.2.1.1. Product breakdown estimates & forecasts, 2018-2028
9.2.1.2. Application breakdown estimates & forecasts, 2018-2028
9.2.1.3. End User breakdown estimates & forecasts, 2018-2028
9.2.2. Canada Extracorporeal CO2 Removal Devices Market
9.3. Europe Extracorporeal CO2 Removal Devices Market Snapshot
9.3.1. U.K. Extracorporeal CO2 Removal Devices Market
9.3.2. Germany Extracorporeal CO2 Removal Devices Market
9.3.3. France Extracorporeal CO2 Removal Devices Market
9.3.4. Spain Extracorporeal CO2 Removal Devices Market
9.3.5. Italy Extracorporeal CO2 Removal Devices Market
9.3.6. Rest of Europe Extracorporeal CO2 Removal Devices Market
9.4. Asia-Pacific Extracorporeal CO2 Removal Devices Market Snapshot
9.4.1. China Extracorporeal CO2 Removal Devices Market
9.4.2. India Extracorporeal CO2 Removal Devices Market
9.4.3. Japan Extracorporeal CO2 Removal Devices Market
9.4.4. Australia Extracorporeal CO2 Removal Devices Market
9.4.5. South Korea Extracorporeal CO2 Removal Devices Market
9.4.6. Rest of Asia Pacific Extracorporeal CO2 Removal Devices Market
9.5. Latin America Extracorporeal CO2 Removal Devices Market Snapshot
9.5.1. Brazil Extracorporeal CO2 Removal Devices Market
9.5.2. Mexico Extracorporeal CO2 Removal Devices Market
9.6. Rest of The World Extracorporeal CO2 Removal Devices Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Medtronic
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Getinge AB
10.2.3. Xenios AG
10.2.4. Alung Technologies
10.2.5. ESTOR S.P.A
10.2.6. Medica Spa
10.2.7. Aferectica Srl
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption



★調査レポート[世界の体外式CO2除去装置市場2022-2028:製品別(体外式CO2除去装置、使い捨て型用品、その他)、用途別、エンドユーザー別、地域別] (コード:BZW22OT0072)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の体外式CO2除去装置市場2022-2028:製品別(体外式CO2除去装置、使い捨て型用品、その他)、用途別、エンドユーザー別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆